Evidence for the activation of vitamin D compounds in the skin by side- chain hydroxylation

Pharmacology and Toxicology

Volumn 82, Issue 4, 1998, Pages 173-176

  Gniadecki, Robert ^a,b,c   Calverley, Martin J ^a  

^a LEO PHARMA A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LEXACALCITOL; MC 1582; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONFORMATIONAL TRANSITION; DRUG EFFECT; DRUG FORMULATION; DRUG HYDROXYLATION; DRUG METABOLISM; EPIDERMIS HYPERPLASIA; HORMONE RECEPTOR INTERACTION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TOPICAL DRUG ADMINISTRATION;

ANIMALIA; MUS MUSCULUS;

EID: 0031966542     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01420.x     Document Type: Article

References (22)

1. Armbrecht, H. J., K. Okuda, N. Wongsurawat, R. K. Nemani, M. L. Chen & M. A. Boltz: Characterization and regulation of the vitamin D hydroxylases. J Steroid Biochem. Mol. Biol. 1992, 43, 1073-1081.
2. 3 on primary mouse epidermal keratinocyte proliferation. J. Cell Physiol. 1995, 163, 248-256.
3. 3 hormone, on hairless mouse skin in vivo. Brit. J. Dermatol. 1995, 132, 841-852.
4. 3: dependence on cell culture conditions. J. Invest. Dermatol. 1996, 106, 510-516.
5. 3. Biochem. Pharmacol. 1995, 49, 621-624.
6. Guo Y. D., S. Strugnell, D. W. Back, G. Jones: Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side chain positions. Proc. Natl. Acad. Sci. USA. 1993, 90, 8668-8672.
7. Holick, M. F.: Photobiology, physiology, and clinical applications for vitamin D. In: Biochemistry and molecular biology of the skin. Ed.: L. A. Goldsmith. Oxford University Press, New York 1991, 928-956.
8. 3 prolong survival time in mice innoculated with myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 1983, 80, 201-204.
9. 3. Endocrinology 1983, 113, 1950-1957.
10. 3. Bone 1995, 16, 129-135.
11. 3-24-hydroxylase(s) from HL-60 cells. Arch. Biochem. Biophys. 1991, 284, 257-263.
12. Kragballe, K., B. T. Gjertsen, D. De Hoop, T. Karlsmark, P. C. van de Kerkhof, O. Larko, C. Nieboer, J. Roed Petersen, A. Strand & G. Tikjob: Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991, 337, 193-196.
13. 3. In: Vitamin D: Chemistry, biology and clinical applications of the steroid hormone. Eds.: A. W. Norman, R. Bouillon & M. Thomasset. University of California, Riverside 1997, 583-584.
14. Matsumoto, K., Y. Azuma, M. Kiyoki, H. Okumura, K. Hashimoto & K. Yoshikawa: Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes. Biochim. Biophys. Acta 1991, 1092, 311-318.
15. 3 -open-design study. Calcif. Tissue Int. 1986, 39, 209-212.
16. 3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J. Steroid Biochem. Mol. Biol. 1992, 41, 231-240.
17. 3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1α,25-dihydroxyvitamin D3. J. Biol. Chem. 1993, 268, 20022-20030.
18. 3 by human monocytic leukemia cells. FEBS Lett. 1992, 309, 399-401.
19. Pillai, S., D. D. Bikle & P. M. Elias: 1,25-dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J. Biol. Chem. 1988, 263, 5390-5395.
20. 3 by interferon-c-stimulated normal human bone marrow and alveolar macrophages. J. Biol. Chem. 1987, 262, 10931-10937.
21. 3. In: Vitamin D: Chemistry, biology and clinical applications of the steroid hormone. Eds.: A. W. Norman, R. Bouillon & M. Thomasset. University of California, Riverside 1997, 581-582.
22. 3 on the morphologic and biochemical differentiation of cultured human keratinocytes grown in serum-free conditions. J. Invest. Dermatol. 1986, 86, 709-714.